Request for Covid-19 Impact Assessment of this Report
The United States Ophthalmic Anti-infective Preparations market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ophthalmic Anti-infective Preparations market, reaching US$ million by the year 2028. As for the Europe Ophthalmic Anti-infective Preparations landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ophthalmic Anti-infective Preparations players cover Allergan PLC, Bayer AG, F. Hoffmann-La Roche AG, and Johnson and Johnson Vision Care Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Anti-infective Preparations market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Use
Clinic Use
Household
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan PLC
Bayer AG
F. Hoffmann-La Roche AG
Johnson and Johnson Vision Care Inc
Kyowa Kirin Co., Ltd
Novartis International AG
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceuticals Co., Ltd.
Shire PLC
Bausch Health
Lupin Pharmaceuticals
Apotex
Akorn
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Anti-infective Preparations Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ophthalmic Anti-infective Preparations by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ophthalmic Anti-infective Preparations by Country/Region, 2017, 2022 & 2028
2.2 Ophthalmic Anti-infective Preparations Segment by Type
2.2.1 Antibacterial
2.2.2 Antiviral
2.2.3 Antifungal
2.2.4 Anti-parasitic
2.2.5 Others
2.3 Ophthalmic Anti-infective Preparations Sales by Type
2.3.1 Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
2.3.2 Global Ophthalmic Anti-infective Preparations Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ophthalmic Anti-infective Preparations Sale Price by Type (2017-2022)
2.4 Ophthalmic Anti-infective Preparations Segment by Application
2.4.1 Hospital Use
2.4.2 Clinic Use
2.4.3 Household
2.4.4 Other
2.5 Ophthalmic Anti-infective Preparations Sales by Application
2.5.1 Global Ophthalmic Anti-infective Preparations Sale Market Share by Application (2017-2022)
2.5.2 Global Ophthalmic Anti-infective Preparations Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ophthalmic Anti-infective Preparations Sale Price by Application (2017-2022)
3 Global Ophthalmic Anti-infective Preparations by Company
3.1 Global Ophthalmic Anti-infective Preparations Breakdown Data by Company
3.1.1 Global Ophthalmic Anti-infective Preparations Annual Sales by Company (2020-2022)
3.1.2 Global Ophthalmic Anti-infective Preparations Sales Market Share by Company (2020-2022)
3.2 Global Ophthalmic Anti-infective Preparations Annual Revenue by Company (2020-2022)
3.2.1 Global Ophthalmic Anti-infective Preparations Revenue by Company (2020-2022)
3.2.2 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2020-2022)
3.3 Global Ophthalmic Anti-infective Preparations Sale Price by Company
3.4 Key Manufacturers Ophthalmic Anti-infective Preparations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Anti-infective Preparations Product Location Distribution
3.4.2 Players Ophthalmic Anti-infective Preparations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmic Anti-infective Preparations by Geographic Region
4.1 World Historic Ophthalmic Anti-infective Preparations Market Size by Geographic Region (2017-2022)
4.1.1 Global Ophthalmic Anti-infective Preparations Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ophthalmic Anti-infective Preparations Annual Revenue by Geographic Region
4.2 World Historic Ophthalmic Anti-infective Preparations Market Size by Country/Region (2017-2022)
4.2.1 Global Ophthalmic Anti-infective Preparations Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ophthalmic Anti-infective Preparations Annual Revenue by Country/Region
4.3 Americas Ophthalmic Anti-infective Preparations Sales Growth
4.4 APAC Ophthalmic Anti-infective Preparations Sales Growth
4.5 Europe Ophthalmic Anti-infective Preparations Sales Growth
4.6 Middle East & Africa Ophthalmic Anti-infective Preparations Sales Growth
5 Americas
5.1 Americas Ophthalmic Anti-infective Preparations Sales by Country
5.1.1 Americas Ophthalmic Anti-infective Preparations Sales by Country (2017-2022)
5.1.2 Americas Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022)
5.2 Americas Ophthalmic Anti-infective Preparations Sales by Type
5.3 Americas Ophthalmic Anti-infective Preparations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Anti-infective Preparations Sales by Region
6.1.1 APAC Ophthalmic Anti-infective Preparations Sales by Region (2017-2022)
6.1.2 APAC Ophthalmic Anti-infective Preparations Revenue by Region (2017-2022)
6.2 APAC Ophthalmic Anti-infective Preparations Sales by Type
6.3 APAC Ophthalmic Anti-infective Preparations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmic Anti-infective Preparations by Country
7.1.1 Europe Ophthalmic Anti-infective Preparations Sales by Country (2017-2022)
7.1.2 Europe Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022)
7.2 Europe Ophthalmic Anti-infective Preparations Sales by Type
7.3 Europe Ophthalmic Anti-infective Preparations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Anti-infective Preparations by Country
8.1.1 Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022)
8.2 Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Type
8.3 Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Anti-infective Preparations
10.3 Manufacturing Process Analysis of Ophthalmic Anti-infective Preparations
10.4 Industry Chain Structure of Ophthalmic Anti-infective Preparations
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Anti-infective Preparations Distributors
11.3 Ophthalmic Anti-infective Preparations Customer
12 World Forecast Review for Ophthalmic Anti-infective Preparations by Geographic Region
12.1 Global Ophthalmic Anti-infective Preparations Market Size Forecast by Region
12.1.1 Global Ophthalmic Anti-infective Preparations Forecast by Region (2023-2028)
12.1.2 Global Ophthalmic Anti-infective Preparations Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Anti-infective Preparations Forecast by Type
12.7 Global Ophthalmic Anti-infective Preparations Forecast by Application
13 Key Players Analysis
13.1 Allergan PLC
13.1.1 Allergan PLC Company Information
13.1.2 Allergan PLC Ophthalmic Anti-infective Preparations Product Offered
13.1.3 Allergan PLC Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan PLC Main Business Overview
13.1.5 Allergan PLC Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Ophthalmic Anti-infective Preparations Product Offered
13.2.3 Bayer AG Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 F. Hoffmann-La Roche AG
13.3.1 F. Hoffmann-La Roche AG Company Information
13.3.2 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Product Offered
13.3.3 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 F. Hoffmann-La Roche AG Main Business Overview
13.3.5 F. Hoffmann-La Roche AG Latest Developments
13.4 Johnson and Johnson Vision Care Inc
13.4.1 Johnson and Johnson Vision Care Inc Company Information
13.4.2 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Product Offered
13.4.3 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson and Johnson Vision Care Inc Main Business Overview
13.4.5 Johnson and Johnson Vision Care Inc Latest Developments
13.5 Kyowa Kirin Co., Ltd
13.5.1 Kyowa Kirin Co., Ltd Company Information
13.5.2 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Product Offered
13.5.3 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kyowa Kirin Co., Ltd Main Business Overview
13.5.5 Kyowa Kirin Co., Ltd Latest Developments
13.6 Novartis International AG
13.6.1 Novartis International AG Company Information
13.6.2 Novartis International AG Ophthalmic Anti-infective Preparations Product Offered
13.6.3 Novartis International AG Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis International AG Main Business Overview
13.6.5 Novartis International AG Latest Developments
13.7 Pfizer, Inc.
13.7.1 Pfizer, Inc. Company Information
13.7.2 Pfizer, Inc. Ophthalmic Anti-infective Preparations Product Offered
13.7.3 Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer, Inc. Main Business Overview
13.7.5 Pfizer, Inc. Latest Developments
13.8 Regeneron Pharmaceuticals, Inc.
13.8.1 Regeneron Pharmaceuticals, Inc. Company Information
13.8.2 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Product Offered
13.8.3 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Regeneron Pharmaceuticals, Inc. Main Business Overview
13.8.5 Regeneron Pharmaceuticals, Inc. Latest Developments
13.9 Santen Pharmaceuticals Co., Ltd.
13.9.1 Santen Pharmaceuticals Co., Ltd. Company Information
13.9.2 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Product Offered
13.9.3 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Santen Pharmaceuticals Co., Ltd. Main Business Overview
13.9.5 Santen Pharmaceuticals Co., Ltd. Latest Developments
13.10 Shire PLC
13.10.1 Shire PLC Company Information
13.10.2 Shire PLC Ophthalmic Anti-infective Preparations Product Offered
13.10.3 Shire PLC Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shire PLC Main Business Overview
13.10.5 Shire PLC Latest Developments
13.11 Bausch Health
13.11.1 Bausch Health Company Information
13.11.2 Bausch Health Ophthalmic Anti-infective Preparations Product Offered
13.11.3 Bausch Health Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bausch Health Main Business Overview
13.11.5 Bausch Health Latest Developments
13.12 Lupin Pharmaceuticals
13.12.1 Lupin Pharmaceuticals Company Information
13.12.2 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Product Offered
13.12.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Lupin Pharmaceuticals Main Business Overview
13.12.5 Lupin Pharmaceuticals Latest Developments
13.13 Apotex
13.13.1 Apotex Company Information
13.13.2 Apotex Ophthalmic Anti-infective Preparations Product Offered
13.13.3 Apotex Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Apotex Main Business Overview
13.13.5 Apotex Latest Developments
13.14 Akorn
13.14.1 Akorn Company Information
13.14.2 Akorn Ophthalmic Anti-infective Preparations Product Offered
13.14.3 Akorn Ophthalmic Anti-infective Preparations Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Akorn Main Business Overview
13.14.5 Akorn Latest Developments
14 Research Findings and Conclusion
Table 1. Ophthalmic Anti-infective Preparations Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ophthalmic Anti-infective Preparations Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Major Players of Anti-parasitic
Table 7. Major Players of Others
Table 8. Global Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT)
Table 9. Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
Table 10. Global Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & ($ million)
Table 11. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2022)
Table 12. Global Ophthalmic Anti-infective Preparations Sale Price by Type (2017-2022) & (USD/MT)
Table 13. Global Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT)
Table 14. Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Table 15. Global Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022)
Table 16. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2022)
Table 17. Global Ophthalmic Anti-infective Preparations Sale Price by Application (2017-2022) & (USD/MT)
Table 18. Global Ophthalmic Anti-infective Preparations Sales by Company (2020-2022) & (MT)
Table 19. Global Ophthalmic Anti-infective Preparations Sales Market Share by Company (2020-2022)
Table 20. Global Ophthalmic Anti-infective Preparations Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2020-2022)
Table 22. Global Ophthalmic Anti-infective Preparations Sale Price by Company (2020-2022) & (USD/MT)
Table 23. Key Manufacturers Ophthalmic Anti-infective Preparations Producing Area Distribution and Sales Area
Table 24. Players Ophthalmic Anti-infective Preparations Products Offered
Table 25. Ophthalmic Anti-infective Preparations Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Ophthalmic Anti-infective Preparations Sales by Geographic Region (2017-2022) & (MT)
Table 29. Global Ophthalmic Anti-infective Preparations Sales Market Share Geographic Region (2017-2022)
Table 30. Global Ophthalmic Anti-infective Preparations Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Ophthalmic Anti-infective Preparations Sales by Country/Region (2017-2022) & (MT)
Table 33. Global Ophthalmic Anti-infective Preparations Sales Market Share by Country/Region (2017-2022)
Table 34. Global Ophthalmic Anti-infective Preparations Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT)
Table 37. Americas Ophthalmic Anti-infective Preparations Sales Market Share by Country (2017-2022)
Table 38. Americas Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2017-2022)
Table 40. Americas Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT)
Table 41. Americas Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
Table 42. Americas Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT)
Table 43. Americas Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Table 44. APAC Ophthalmic Anti-infective Preparations Sales by Region (2017-2022) & (MT)
Table 45. APAC Ophthalmic Anti-infective Preparations Sales Market Share by Region (2017-2022)
Table 46. APAC Ophthalmic Anti-infective Preparations Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Ophthalmic Anti-infective Preparations Revenue Market Share by Region (2017-2022)
Table 48. APAC Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT)
Table 49. APAC Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
Table 50. APAC Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT)
Table 51. APAC Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Table 52. Europe Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT)
Table 53. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Country (2017-2022)
Table 54. Europe Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2017-2022)
Table 56. Europe Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT)
Table 57. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
Table 58. Europe Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT)
Table 59. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT)
Table 61. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT)
Table 65. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT)
Table 67. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Ophthalmic Anti-infective Preparations
Table 69. Key Market Challenges & Risks of Ophthalmic Anti-infective Preparations
Table 70. Key Industry Trends of Ophthalmic Anti-infective Preparations
Table 71. Ophthalmic Anti-infective Preparations Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Ophthalmic Anti-infective Preparations Distributors List
Table 74. Ophthalmic Anti-infective Preparations Customer List
Table 75. Global Ophthalmic Anti-infective Preparations Sales Forecast by Region (2023-2028) & (MT)
Table 76. Global Ophthalmic Anti-infective Preparations Sales Market Forecast by Region
Table 77. Global Ophthalmic Anti-infective Preparations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Ophthalmic Anti-infective Preparations Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Ophthalmic Anti-infective Preparations Sales Forecast by Country (2023-2028) & (MT)
Table 80. Americas Ophthalmic Anti-infective Preparations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Ophthalmic Anti-infective Preparations Sales Forecast by Region (2023-2028) & (MT)
Table 82. APAC Ophthalmic Anti-infective Preparations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Ophthalmic Anti-infective Preparations Sales Forecast by Country (2023-2028) & (MT)
Table 84. Europe Ophthalmic Anti-infective Preparations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Forecast by Country (2023-2028) & (MT)
Table 86. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Ophthalmic Anti-infective Preparations Sales Forecast by Type (2023-2028) & (MT)
Table 88. Global Ophthalmic Anti-infective Preparations Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Ophthalmic Anti-infective Preparations Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Ophthalmic Anti-infective Preparations Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Ophthalmic Anti-infective Preparations Sales Forecast by Application (2023-2028) & (MT)
Table 92. Global Ophthalmic Anti-infective Preparations Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Ophthalmic Anti-infective Preparations Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Ophthalmic Anti-infective Preparations Revenue Market Share Forecast by Application (2023-2028)
Table 95. Allergan PLC Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 96. Allergan PLC Ophthalmic Anti-infective Preparations Product Offered
Table 97. Allergan PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 98. Allergan PLC Main Business
Table 99. Allergan PLC Latest Developments
Table 100. Bayer AG Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 101. Bayer AG Ophthalmic Anti-infective Preparations Product Offered
Table 102. Bayer AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 103. Bayer AG Main Business
Table 104. Bayer AG Latest Developments
Table 105. F. Hoffmann-La Roche AG Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 106. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Product Offered
Table 107. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 108. F. Hoffmann-La Roche AG Main Business
Table 109. F. Hoffmann-La Roche AG Latest Developments
Table 110. Johnson and Johnson Vision Care Inc Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Product Offered
Table 112. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 113. Johnson and Johnson Vision Care Inc Main Business
Table 114. Johnson and Johnson Vision Care Inc Latest Developments
Table 115. Kyowa Kirin Co., Ltd Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 116. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Product Offered
Table 117. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 118. Kyowa Kirin Co., Ltd Main Business
Table 119. Kyowa Kirin Co., Ltd Latest Developments
Table 120. Novartis International AG Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 121. Novartis International AG Ophthalmic Anti-infective Preparations Product Offered
Table 122. Novartis International AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 123. Novartis International AG Main Business
Table 124. Novartis International AG Latest Developments
Table 125. Pfizer, Inc. Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer, Inc. Ophthalmic Anti-infective Preparations Product Offered
Table 127. Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 128. Pfizer, Inc. Main Business
Table 129. Pfizer, Inc. Latest Developments
Table 130. Regeneron Pharmaceuticals, Inc. Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 131. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Product Offered
Table 132. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 133. Regeneron Pharmaceuticals, Inc. Main Business
Table 134. Regeneron Pharmaceuticals, Inc. Latest Developments
Table 135. Santen Pharmaceuticals Co., Ltd. Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 136. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Product Offered
Table 137. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 138. Santen Pharmaceuticals Co., Ltd. Main Business
Table 139. Santen Pharmaceuticals Co., Ltd. Latest Developments
Table 140. Shire PLC Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 141. Shire PLC Ophthalmic Anti-infective Preparations Product Offered
Table 142. Shire PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 143. Shire PLC Main Business
Table 144. Shire PLC Latest Developments
Table 145. Bausch Health Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 146. Bausch Health Ophthalmic Anti-infective Preparations Product Offered
Table 147. Bausch Health Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 148. Bausch Health Main Business
Table 149. Bausch Health Latest Developments
Table 150. Lupin Pharmaceuticals Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 151. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Product Offered
Table 152. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 153. Lupin Pharmaceuticals Main Business
Table 154. Lupin Pharmaceuticals Latest Developments
Table 155. Apotex Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 156. Apotex Ophthalmic Anti-infective Preparations Product Offered
Table 157. Apotex Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 158. Apotex Main Business
Table 159. Apotex Latest Developments
Table 160. Akorn Basic Information, Ophthalmic Anti-infective Preparations Manufacturing Base, Sales Area and Its Competitors
Table 161. Akorn Ophthalmic Anti-infective Preparations Product Offered
Table 162. Akorn Ophthalmic Anti-infective Preparations Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 163. Akorn Main Business
Table 164. Akorn Latest Developments
List of Figures
Figure 1. Picture of Ophthalmic Anti-infective Preparations
Figure 2. Ophthalmic Anti-infective Preparations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Anti-infective Preparations Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Ophthalmic Anti-infective Preparations Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ophthalmic Anti-infective Preparations Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antibacterial
Figure 10. Product Picture of Antiviral
Figure 11. Product Picture of Antifungal
Figure 12. Product Picture of Anti-parasitic
Figure 13. Product Picture of Others
Figure 14. Global Ophthalmic Anti-infective Preparations Sales Market Share by Type in 2021
Figure 15. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2022)
Figure 16. Ophthalmic Anti-infective Preparations Consumed in Hospital Use
Figure 17. Global Ophthalmic Anti-infective Preparations Market: Hospital Use (2017-2022) & (MT)
Figure 18. Ophthalmic Anti-infective Preparations Consumed in Clinic Use
Figure 19. Global Ophthalmic Anti-infective Preparations Market: Clinic Use (2017-2022) & (MT)
Figure 20. Ophthalmic Anti-infective Preparations Consumed in Household
Figure 21. Global Ophthalmic Anti-infective Preparations Market: Household (2017-2022) & (MT)
Figure 22. Ophthalmic Anti-infective Preparations Consumed in Other
Figure 23. Global Ophthalmic Anti-infective Preparations Market: Other (2017-2022) & (MT)
Figure 24. Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022)
Figure 25. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application in 2021
Figure 26. Ophthalmic Anti-infective Preparations Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Company in 2021
Figure 28. Global Ophthalmic Anti-infective Preparations Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Geographic Region in 2021
Figure 30. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region (2017-2022)
Figure 31. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Country/Region in 2021
Figure 32. Americas Ophthalmic Anti-infective Preparations Sales 2017-2022 (MT)
Figure 33. Americas Ophthalmic Anti-infective Preparations Revenue 2017-2022 ($ Millions)
Figure 34. APAC Ophthalmic Anti-infective Preparations Sales 2017-2022 (MT)
Figure 35. APAC Ophthalmic Anti-infective Preparations Revenue 2017-2022 ($ Millions)
Figure 36. Europe Ophthalmic Anti-infective Preparations Sales 2017-2022 (MT)
Figure 37. Europe Ophthalmic Anti-infective Preparations Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Ophthalmic Anti-infective Preparations Sales 2017-2022 (MT)
Figure 39. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue 2017-2022 ($ Millions)
Figure 40. Americas Ophthalmic Anti-infective Preparations Sales Market Share by Country in 2021
Figure 41. Americas Ophthalmic Anti-infective Preparations Revenue Market Share by Country in 2021
Figure 42. United States Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Ophthalmic Anti-infective Preparations Sales Market Share by Region in 2021
Figure 47. APAC Ophthalmic Anti-infective Preparations Revenue Market Share by Regions in 2021
Figure 48. China Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Country in 2021
Figure 55. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Country in 2021
Figure 56. Germany Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Country in 2021
Figure 63. Egypt Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Ophthalmic Anti-infective Preparations Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Ophthalmic Anti-infective Preparations in 2021
Figure 69. Manufacturing Process Analysis of Ophthalmic Anti-infective Preparations
Figure 70. Industry Chain Structure of Ophthalmic Anti-infective Preparations
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...